Visualization of gene therapy with a liver cancer-targeted adeno-associated virus 3 vector

Background: To evaluate the feasibility of a self-complementing recombinant adeno-associated virus 3 (scrAAV3) vector targeting liver cancer and non-invasively monitor gene therapy of liver cancer. Materials and methods: An scrAAV3-HSV1-TK-kallistatin (ATK) gene drug was constructed, which contained...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xusheng, Huang, Hanling, Gao, Yan, Zhou, Lumeng, Yang, Jianwei, Li, Xiaohui, Li, Yang, Zhao, Haiwen, Su, Shanchun, Ke, Changbin, Pei, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052912/
https://www.ncbi.nlm.nih.gov/pubmed/32127946
http://dx.doi.org/10.7150/jca.39579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052912/
https://www.ncbi.nlm.nih.gov/pubmed/32127946
http://dx.doi.org/10.7150/jca.39579

Ejemplares similares